Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BOND LABORATORIES, INC. | 322,482 | reported | 16 Jan 2016 | tx 11+5,121,565−830,518 |
| NRX Pharmaceuticals, Inc. | 50,000 | reported | 07 Feb 2025 | tx 1+50,000 |
| Arch Therapeutics, Inc. | 10,292 | reported | 31 Aug 2023 | tx 7+2,149,874 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Feb 2025 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 31 Aug 2023 | PURCHASE | Arch Therapeutics, Inc. | 10,292 | 0.28 USD | first after silence |
| 31 Aug 2023 | GRANT_AWARD | Arch Therapeutics, Inc. | 20,584 | — | deriv |
| 10 Nov 2022 | GRANT_AWARD | Arch Therapeutics, Inc. | 900,000 | 0.00 USD | deriv |
| 06 Jul 2022 | GRANT_AWARD | Arch Therapeutics, Inc. | 108,652 | — | |
| 06 Jul 2022 | GRANT_AWARD | Arch Therapeutics, Inc. | 724,346 | — | deriv |
| 06 Jul 2022 | GRANT_AWARD | Arch Therapeutics, Inc. | 36,000 | — | deriv |
| 27 Sept 2021 | GRANT_AWARD | Arch Therapeutics, Inc. | 350,000 | 0.00 USD | deriv |
| 16 Jan 2016 | TAX_WITHHOLDING | BOND LABORATORIES, INC. | 80,518 | 1.30 USD | |
| 23 Feb 2015 | GRANT_AWARD | BOND LABORATORIES, INC. | 50,000 | 0.00 USD | deriv |
| 11 Jun 2014 | PURCHASE | BOND LABORATORIES, INC. | 1,000 | 2.15 USD | first after silence |
| 28 Dec 2012 | PURCHASE | BOND LABORATORIES, INC. | 1,050,565 | — | |
| 08 Aug 2012 | OTHER | BOND LABORATORIES, INC. | 120,000 | 0.05 USD | |
| 09 May 2012 | GRANT_AWARD | BOND LABORATORIES, INC. | 100,000 | 0.09 USD | deriv |
| 31 Dec 2010 | OTHER | BOND LABORATORIES, INC. | 625,000 | — | |
| 31 Dec 2010 | OTHER | BOND LABORATORIES, INC. | 375,000 | 0.35 USD | deriv |
| 31 Dec 2010 | OTHER | BOND LABORATORIES, INC. | 375,000 | 0.50 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 31 Aug 2023.